Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichi Enjyoji

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Blood|January 5, 2022
Vasculopathy in COVID-19Robert Flaumenhaft, Keiichi Enjyoji, Alec A Schmaier
Blood Cells, Molecules & Diseases|February 16, 2006
Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targetsBen Atkinson, Karen Dwyer, Keiichi Enjyoji, et al.
International Journal of Cardiology|July 2, 2008
HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteriesXinhua Yin, Yu Fu, Chikao Yutani, et al.
European Journal of Immunology|March 5, 2010
NTPDase1 governs P2X7-dependent functions in murine macrophagesSébastien A Lévesque, Filip Kukulski, Keiichi Enjyoji, et al.
Seminars in Thrombosis and Hemostasis|April 27, 2005
Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantationSimon C Robson, Yan Wu, Xiaofeng Sun, et al.
Diabetes|May 3, 2007
The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathyDavid J Friedman, Helmut G Rennke, Eva Csizmadia, et al.
Nature Medicine|April 3, 2002
CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsivenessNorikatsu Mizumoto, Tadashi Kumamoto, Simon C Robson, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolismGuido Beldi, Keiichi Enjyoji, Yan Wu, et al.
Purinergic Signalling|March 25, 2009
Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in miceAmir Behdad, Xiaofeng Sun, Zain Khalpey, et al.
Gastroenterology|June 16, 2010
CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in miceXiaofeng Sun, Yan Wu, Wenda Gao, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Blood|January 5, 2022
Vasculopathy in COVID-19Robert Flaumenhaft, Keiichi Enjyoji, Alec A Schmaier
Blood Cells, Molecules & Diseases|February 16, 2006
Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targetsBen Atkinson, Karen Dwyer, Keiichi Enjyoji, et al.
International Journal of Cardiology|July 2, 2008
HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteriesXinhua Yin, Yu Fu, Chikao Yutani, et al.
European Journal of Immunology|March 5, 2010
NTPDase1 governs P2X7-dependent functions in murine macrophagesSébastien A Lévesque, Filip Kukulski, Keiichi Enjyoji, et al.
Seminars in Thrombosis and Hemostasis|April 27, 2005
Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantationSimon C Robson, Yan Wu, Xiaofeng Sun, et al.
Diabetes|May 3, 2007
The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathyDavid J Friedman, Helmut G Rennke, Eva Csizmadia, et al.
Nature Medicine|April 3, 2002
CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsivenessNorikatsu Mizumoto, Tadashi Kumamoto, Simon C Robson, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolismGuido Beldi, Keiichi Enjyoji, Yan Wu, et al.
Purinergic Signalling|March 25, 2009
Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in miceAmir Behdad, Xiaofeng Sun, Zain Khalpey, et al.
Gastroenterology|June 16, 2010
CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in miceXiaofeng Sun, Yan Wu, Wenda Gao, et al.
Pageof 5